Respiratory Mechanics and Metabolic Changes During Low Pressure Laparoscopic Cholecystectomy
NCT ID: NCT02469831
Last Updated: 2017-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
40 participants
INTERVENTIONAL
2014-10-31
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Magnesium Sulfate Effects on Onset and Duration of Low Dose Rocuronium in Patients Undergoing Laparoscopic Cholecystectomy
NCT02669368
Deep vs Moderate Neuromuscular Blockade in Day Case Laparoscopic Cholecystectomy.
NCT03881423
Retrolaminar Block Versus Intraperitoneal Block for Laparoscopic Cholecystectomy
NCT05755815
The Effect of Intraoperative Labetalol on Time to Discharge
NCT02997800
Low-pressure vs Standard-pressure in Laparoscopic Cholecystectomy
NCT04146090
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group D
deep neuromuscular block by rocuronium defined :post tetanic (PTC) \>1 but no response to a train of four (TOF) stimulation.
Rocuronium
group I
intermediate neuromuscular block by rocuronium defined as TOF count of 1-3.
Rocuronium
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rocuronium
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* undergoing elective laparoscopic cholecystectomy
Exclusion Criteria
* a history of venous or arterial diseases,
* BMI (≥30 kg/m2),
* Allergy to rocuronium.
* Significant liver dysfunction.
* Significant renal dysfunction (S-creatinine \> 200 umol/l).
* Neuromuscular disease that might impair neuromuscular blockade
* Pregnant or breastfeeding.
* Indication for rapid sequence induction.
* Inability to informed consent
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
khaled salah mohamed
lecturer of anaesthesia and ICU
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Osama ibraheim, MD
Role: STUDY_CHAIR
Assiut University
MOSTAFA ABBAS, MD
Role: STUDY_CHAIR
Assiut University
AHMED TAHA, MD
Role: STUDY_CHAIR
Assiut University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Al Rajhy liver hospital
Asyut, Asyut Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
low pressure lap chole.
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.